ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,678.55
      1.36%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. CV Therapeutics (MM) (CVTX)

      7. CV Therapeutics (MM) (CVTX) News

      CVTX

      CV Therapeutics (CVTX)

      CV Therapeutics (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CVTX
      DateTimeSourceHeadlineSymbolCompany
      03/12/20095:01PMEdgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:CVTXCV Therapeutics (MM)
      03/12/20094:53PMEdgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:CVTXCV Therapeutics (MM)
      03/12/20094:42PMDow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNASDAQ:CVTXCV Therapeutics Inc.
      03/12/20092:15PMPR Newswire (US)CV Therapeutics' Board of Directors Rejects Astellas' Tender OfferNASDAQ:CVTXCV Therapeutics (MM)
      03/12/200910:06AMDow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionNASDAQ:CVTXCV Therapeutics Inc.
      03/12/20099:22AMDow Jones NewsGilead To Buy CV Therapeutics For $1.4 Billion In White-Knight BidNASDAQ:CVTXCV Therapeutics Inc.
      03/12/20098:06AMBusiness WireGilead Sciences Agrees to Acquire CV Therapeutics for $20.00 Per ShareNASDAQ:CVTXCV Therapeutics (MM)
      03/06/20091:52PMEdgar (US Regulatory)Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)NASDAQ:CVTXCV Therapeutics (MM)
      03/06/20091:51PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
      03/06/20098:00AMBusiness WireAstellas to Nominate Two Directors and Submit Proposal to Remove Remaining Four Directors of CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
      03/05/20092:41PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
      03/05/20098:30AMMarketwiredCV Therapeutics Reports Phase 1 Data Showing Proof of Concept for CVT-3619, a Novel Potential Treatment for Cardiometabolic DiseNASDAQ:CVTXCV Therapeutics (MM)
      03/04/20092:34PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
      03/03/200912:27PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
      03/03/20098:30AMMarketwiredRanexa(R) Now Available in United Kingdom and GermanyNASDAQ:CVTXCV Therapeutics (MM)
      02/27/20095:28PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
      02/27/20094:10PMEdgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:CVTXCV Therapeutics (MM)
      02/27/20093:05PMPR Newswire (US)CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender OfferNASDAQ:CVTXCV Therapeutics (MM)
      02/27/200910:05AMBusiness WireAstellas Files Lawsuit against CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
      02/27/20094:00AMBusiness WireAstellas Commences Tender Offer to Acquire All Outstanding Shares of CV Therapeutics for $16.00 Per Share in CashNASDAQ:CVTXCV Therapeutics (MM)
      02/26/20093:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      02/26/20093:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      02/26/20093:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      02/26/20093:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      02/26/20093:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
      02/25/20093:33PMEdgar (US Regulatory)Annual Report (10-K)NASDAQ:CVTXCV Therapeutics (MM)
      02/23/20092:00AMBusiness WireAstellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash ProposalNASDAQ:CVTXCV Therapeutics (MM)
      02/20/20094:35PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
      02/20/20099:25AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
      02/20/20096:06AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
       Showing the most relevant articles for your search:NASDAQ:CVTX

      Your Recent History

      BIT
      UB30FE
      UniCredit Bank
      BIT
      NSCIT0110493
      Federal Republic
      Delayed Upgrade Clock